Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV …

Once again, deals and collaborations made news in the biotech sector with BioMarin (BMRN – Analyst Report) announcing its intention to acquire Prosensa (RNA – Snapshot Report) and Five Prime Therapeutics (FPRX – Snapshot Report) signing a second immuno-oncology focused deal with Bristol-Myers Squibb.Meanwhile, AbbVie (ABBV – Analyst Report) continues to progress with its hepatitis C virus (HCV) treatment with […]

Best Mutual Funds for Aggressive Investors

istockphotoThree-year annualized return: 28.1%Annual expense ratio: 0.35%Minimum initial investment: $3,000Biggest holdings: Actavis, Merck, Bristol-Myers Squibb, UnitedHealth Group, AstraZenecaVanguard Health Care (VGHCX) is the Grand Pooh-Bah of health care sector funds. Not only is it the biggest, it also charges the least of any health care mutual fund (exchange-traded funds tend to cost less). What’s more, even as Vanguard Health outpaced […]